MC
VCNX

Moors & Cabot’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Moors & Cabot’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-48
Closed -$3.56K – 887
2023
Q2 		$3.56K Hold
48
– – ﹤0.01% 832
2023
Q1 		$4K Hold
48
– – ﹤0.01% 854
2022
Q4 		$6.45K Hold
48
– – ﹤0.01% 833
2022
Q3 		$5K Hold
48
– – ﹤0.01% 810
2022
Q2 		$11K Hold
48
– – ﹤0.01% 793
2022
Q1 		$13K Buy
+48
New +$13.3K ﹤0.01% 856

Other funds holding VCNX

ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
TC
Tacita Capital Toronto, Ontario, Canada $169M AUM 24.7% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return